Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. a Lyon-Marseille-Curie-east of France Group Study
Michon, J.; Négrier, S.; Coze, C.; Mathiot, C.; Frappaz, D.; Oskam, R.; Pacquement, H.; Quintana, E.; Bouffet, E.; Bernard, J.L.
Progress in Clinical and Biological Research 385: 293-300
1994
ISSN/ISBN: 0361-7742 PMID: 7972223 Document Number: 435662
Document emailed within 1 workday
Related Documents
Blaise, D.; Viens, P.; Olive, D.; Stoppa, A.M.; Gabert, J.; Pourreau, C.N.; Attal, M.; Gaspard, M.H.; Mannoni, P.; Jasmin, C. 1991: Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patients European Cytokine Network 2(2): 121-129De Kreuk, M.; Ossenkoppele, G.J.; Meijer, C.J.; Huijgens, P.C. 1996: Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 17(6): 963-971
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Mukaiyama, T.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Fukutani, H.; Tabata, M.; Hirano, A.; Mizunuma, N.; Itami, S. 1989: A study to overcome drug resistance using high-dose chemotherapy with autologous bone marrow transplantation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 2013-2018
Vasta, S.; Scimé, R.; Indovina, A.; Majolino, I. 1992: CNS toxicity and high-dose busulphan in three patients undergoing bone marrow transplantation Haematologica 77(2): 189
Verdonck, L.F.; Vendrik, C.P.; Dekker, A.W.; van Kempen, M.L.; Schornagel, J.H.; Rozenberg-Arska, M.; de Gast, G.C. 1985: High dose cytotoxic agents followed by autologous bone marrow transplantation; treatment results in 25 patients with various malignancies Nederlands Tijdschrift Voor Geneeskunde 129(25): 1186-1190
Ahmed, T.; Ciavarella, D.; Feldman, E.; Ascensao, J.; Hussain, F.; Engelking, C.; Gingrich, S.; Mittelman, A.; Coleman, M.; Arlin, Z.A. 1989: High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease Leukemia 3(1): 19-22
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Linassier, C.; Fouillard, L.; Milpied, N.; Tilly, H.; Pico, J.; Abgrall, J.F.; Coiffier, B.; Herbrecht, R.; Biron, P.; Colombat, P. 1996: Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study Cancer Detection and Prevention 20(1): 11-19
Lopez, M.; Mortel, O.; Pouillart, P.; Zucker, J.M.; Fechtenbaum, J.; Douay, L.; Palangie, T.; Michon, J.; Salmon, D. 1990: Infusion of autologous peripheral blood nucleated cells hastens hematological recovery after high dose chemotherapy and autologous transplantation of bone marrow Bone Marrow Transplantation 5 Suppl. 1: 44-45
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Mesía, R.; Solá, C.; López Pousa, A.; Mendoza, L.; Bellet, M.; Andrés, L.; López López, J.J. 1994: High-dose chemotherapy and autologous bone marrow transplantation in high-grade metastatic sarcomas Revista Clinica Espanola 194(11): 960-965
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Chastagner, P.; Hartmann, O.; Tancrede, C.; Kalifa, C.; Patte, C.; Flamant, F.; Lemerle, J. 1989: Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. a study in children treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 4(4): 393-398
Schouten, H.C.; Maragos, D.; Vose, J.; Armitage, J.O. 1990: Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation Bone Marrow Transplantation 6(5): 333-335
Takeyama, K.; Tobinai, K.; Shimoyama, M. 1992: High dose chemotherapy with autologous bone marrow transplantation and G-CSF for hematologic malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 50(6): 1414-1418
Gorin, N.C.; Najman, A.; David, R.; Stachowiak, J.; Hirsch Marie, F.; Muller, J.Y.; Petit, J.C.; Leblanc, G.; Parlier, Y.; Jullien, A.M.; Cavalier, J.; Salmon, C.; Duhamel, G. 1978: High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells La Nouvelle Presse Medicale 7(45): 4105-4110
Wolff, S.N.; Herzig, R.H.; Fay, J.W.; LeMaistre, C.F.; Brown, R.A.; Frei-Lahr, D.; Stranjord, S.; Giannone, L.; Coccia, P.; Weick, J.L. 1990: High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase i studies Seminars in Oncology 17(1 Suppl 3: 2-6
Fine, H.A.; Antman, K.H. 1992: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience Bone Marrow Transplantation 10(4): 315-321
Milliken, S.; Powles, R.; Jones, A.; Helenglass, G. 1989: Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan Transplantation Proceedings 21(1 Pt 3): 3067